Prostate Cancer
Metastatic castration-resistant prostate cancer. Part 1: The challenges of the disease and its treatment - Abstract
February 22, 2014
Real-time elastography for the detection of prostate cancer - Abstract
February 22, 2014
Quantitative EMG of external urethral sphincter in neurologically healthy men with prostate pathology - Abstract
February 22, 2014
A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT - Abstract
February 22, 2014
Surgical quality is more than volume: The association between changing urologists and complications for patients with localized prostate cancer - Abstract
February 22, 2014
Statins: Protectors or pretenders in prostate cancer? - Abstract
February 22, 2014
Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era - Abstract
February 22, 2014
Identification of men with the highest risk of early disease recurrence after radical prostatectomy - Abstract
February 21, 2014
The prostate cancer risk stratification project: Database construction and risk stratification outcome analysis - Abstract
February 21, 2014
Patient reported outcome measure (PROM) of quality of life after prostatectomy - Results from a 5-year study - Abstract
February 21, 2014
What is the clinical significance of FDG unexpected uptake in the prostate in patients undergoing PET/CT for other malignancies? - Abstract
February 21, 2014
Can single positive core prostate cancer at biopsy be considered a low-risk disease after radical prostatectomy? - Abstract
February 21, 2014
Metastatic castration-resistant prostate cancer (CRPC): Preclinical and clinical evidence for the sequential use of novel therapeutics - Abstract
February 21, 2014